Home/Drugs/Zinpentraxin alfa

Zinpentraxin alfa

zinpentraxin-alfa

Phase 2a

Sponsor: Roche / Promedior

Indication: IPF

Mechanism of Action

Recombinant human pentraxin-2 (PTX-2)

Target: PTX-2

Clinical Information

Clinical Trials (ClinicalTrials.gov)

TERMINATEDNCT04552899

Phase:PHASE3Org:Hoffmann-La Roche

TERMINATED

Relevant Publications (PubMed)

No recent publications found for zinpentraxin-alfa.

Validated Models

This drug has been validated in the following preclinical models: